Biometrics

Statistical Consulting

Optimize your clinical development—from study design to submission and beyond—with our innovative statistical strategies

Reduce costs and timeline of your clinical trial

Our dedicated, in-house experts use the most innovative methods to support the development of study designs across a wide range of therapeutic areas and phases for both medical devices and drugs.

We’ll work closely with you to support regulatory interactions and oversight implementation.

No matter how complex your project, get tailored, comprehensive support, including:
  • Statistical strategy for clinical development plans
  • Study design and protocol development
  • Power and Sample size calculation
  • Implementation of complex statistical methodologies
  • Support for interim analyses
  • Support for Data Monitoring Committees / Data Safety Monitoring Boards
  • Support for regulatory interactions

Why choose Alira Health?

Alira Health biometrics team has provided expert statistical guidance for over 500 projects. As our partner, you’ll benefit from:

  • Working with the subject matter experts and statistical consultants with over 20 years of clinical development experience
  • Strategic input on clinical development plans and protocols
  • Strong know-how in the latest statistical methods
  • Direct access to an in-house team of regulatory experts

Related News

Events February 2, 2023
ACDM 2023
We are pleased to announce that we will be sponsoring and attending ACDM 2023. ACDM23 offers a full two-day program of expert speakers, specialist panels, workshops and debates which(...)
Clinical Data Science
Blog December 21, 2022
2022 Recap: Your Favorite Alira Health Publications
In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance(...)
Clinical Digital Health Market Access MedTech Pharma Regulatory
Blog December 14, 2022
How to Optimize Clinical Research with Patient Advisory Boards
Patient engagement is increasingly essential to all stages of product development—particularly clinical research.
Clinical Patient Advocacy Patient Centric
Events November 30, 2022
Innovations in Wound Healing
We are excited to attend and sponsor a poster presentation at the Innovations in Wound Healing event this year. This unique meeting is led by a group of experienced educators, scientists(...)
Clinical Patient Centric Wound Healing
Publications September 16, 2022
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Biometrics Clinical eCOA
Blog September 7, 2022
The Promise and Reality of Decentralized and Hybrid Clinical Trials in Europe Today
To understand the challenges related to hybrid and decentralized trials and ways to overcome them, we spoke with Dr. Hervé Solatges, Product Management, Evidence, and Innovation (DCT(...)
Clinical Decentralized Clinical Trials Hybrid Clinical Trials
Blog September 5, 2022
Taking In-Licensed Biologics to Market: Challenges, Complexities, and Ways to Overcome Them
Taking a biologic through drug development to market is highly complex and filled with challenges. To understand these challenges, their implications and how to overcome them, we spoke(...)
Biologics Clinical Drug Development
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.